These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16805076)

  • 21. Prevention is better than cure: guidelines for colorectal cancer screening are missing the mark.
    Tan KY; Seow-Choen F
    Colorectal Dis; 2007 Nov; 9(9):784-6. PubMed ID: 17931168
    [No Abstract]   [Full Text] [Related]  

  • 22. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
    Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suggested technique for fecal occult blood testing and interpretation in colorectal cancer screening. American College of Physicians.
    Ann Intern Med; 1997 May; 126(10):808-10. PubMed ID: 9148657
    [No Abstract]   [Full Text] [Related]  

  • 24. Fecal occult blood testing for colorectal cancer. Can we afford to do this?
    Ahlquist DA
    Gastroenterol Clin North Am; 1997 Mar; 26(1):41-55. PubMed ID: 9119439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized controlled trial of a clinic-based support staff intervention to increase the rate of fecal occult blood test ordering.
    Thompson NJ; Boyko EJ; Dominitz JA; Belcher DW; Chesebro BB; Stephens LM; Chapko MK
    Prev Med; 2000 Mar; 30(3):244-51. PubMed ID: 10684748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Judging the guidelines for colorectal cancer screening.
    Woolf SH; Ganiats TG
    Am Fam Physician; 1997 Jun; 55(8):2595, 2598-600. PubMed ID: 9191445
    [No Abstract]   [Full Text] [Related]  

  • 28. [Does yearly fecal exam for occult blood lower colorectal cancer mortality?].
    Gerbes L; Jüngst D; Köbberling J
    Z Gastroenterol; 1994 Oct; 32(10):603-6. PubMed ID: 7716998
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical guidelines for the prevention of colorectal cancer].
    Castells A; Marzo M; Bellas B; Amador FJ; Lanas A; Mascort JJ; Ferrándiz J; Alonso P; Piñol V; Fernández M; Bonfill X; Piqué JM
    Gastroenterol Hepatol; 2004 Dec; 27(10):573-634. PubMed ID: 15574281
    [No Abstract]   [Full Text] [Related]  

  • 30. Screening for colorectal cancer: the accuracy of fecal occult blood.
    Greegor DH
    JAMA; 1993 Jul; 270(4):451; author reply 452-3. PubMed ID: 8357422
    [No Abstract]   [Full Text] [Related]  

  • 31. Colorectal cancer screening in Canada: results of a national survey.
    Sewitch MJ; Fournier C; Ciampi A; Dyachenko A
    Chronic Dis Can; 2008; 29(1):9-21. PubMed ID: 19036219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Digital rectal fecal occult blood screening during gynecologic examination.
    Willis FL; Fanning J
    Am J Obstet Gynecol; 2004 May; 190(5):1422-3. PubMed ID: 15167856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decision making in colorectal cancer screening.
    Trowers E; Nguyen W; Cobos E
    J Natl Med Assoc; 1997 Jan; 89(1):9-12. PubMed ID: 9002411
    [No Abstract]   [Full Text] [Related]  

  • 34. Application of the fecal microRNA test to the residuum from the fecal occult blood test.
    Yamazaki N; Koga Y; Yamamoto S; Kakugawa Y; Otake Y; Hayashi R; Saito N; Matsumura Y
    Jpn J Clin Oncol; 2013 Jul; 43(7):726-33. PubMed ID: 23677957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colorectal cancer screening: clinical applications.
    Walsh JM; Terdiman JP
    JAMA; 2003 Mar; 289(10):1297-302. PubMed ID: 12633192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fecal occult blood testing for colorectal cancer in an ethnically diverse population.
    Glober GA; Hundahl S; Stucke J; Choy M
    West J Med; 1994 Oct; 161(4):377-82. PubMed ID: 7817548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NICE referral guidelines for suspected cancer: colorectal cancer and faecal occult blood testing.
    Benton S; Steele R; Logan R; Djedovic N; Smith S; Addison C
    Ann Clin Biochem; 2016 Jan; 53(Pt 1):7-9. PubMed ID: 26438519
    [No Abstract]   [Full Text] [Related]  

  • 38. Screening for colorectal cancer: the accuracy of fecal occult blood.
    Young GP; St John DJ
    JAMA; 1993 Jul; 270(4):451-2; author reply 452-3. PubMed ID: 8320780
    [No Abstract]   [Full Text] [Related]  

  • 39. Colorectal cancer screening.
    McLoughlin RM; O'Morain CA
    World J Gastroenterol; 2006 Nov; 12(42):6747-50. PubMed ID: 17106920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colorectal cancer screening by fecal occult blood testing: results of a population-based experience.
    Grazzini G; Castiglione G; Isu A; Mantellini P; Rubeca T; Sani C; Turco P; Zappa M
    Tumori; 2000; 86(5):384-8. PubMed ID: 11130566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.